Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Umbilical Cord-derived Mesenchymal Stem Cell Injectables for Partial-thickness Rotator Cuff Tears
NCT07605559Not yet recruiting
- Start
- May 2026
- Primary completion
- Dec 2027
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Randomised trial of human umbilical cord mesenchymal stem cells in rotator cuff disease (3 arms). Primary endpoint: Changes in the size of rotator cuff tears determined by MRI at 6 months. Planned start May 2026; status: not yet recruiting.
02
Drugs
human umbilical cord mesenchymal stem cells
03
Conditions
rotator cuff disease
Beyond the preview
Go deeper on NCT07605559.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07605559.